Melatonin in the Context of Women's Health
https://doi.org/10.17021/1992-6499-2026-1-27-33
Abstract
The article presents the results of research by foreign and domestic authors on the role of melatonin in women's reproductive health. Melatonin (N-acetyl-5-methoxytryptamine) is the main hormone of the pineal gland and has a wide range of biological effects, including antioxidant, immunomodulatory, cancer-protective, antidepressant, anticonvulsant, hypocholesterolemic, and hypoglycemic effects. In the reproductive system, it promotes follicular maturation, gametogenesis, fertilization, and embryo implantation, protecting reproductive cells and chorionic tissue from free radicals. By systematizing existing knowledge, it will be possible to justify the need for research on biomarkers in reproductive system dysfunction, particularly in secondary functional oligomenorrhea.
About the Authors
M. G. Nikolaeva
Altai State Medical University;
RZD-Medicine
Russian Federation
Russian Federation
Maria G. Nikolaeva, Dr. Sci. (Med), Professor, Professor of the Department;
Obstetrician-Gynecologist
Barnaul
Yu. M. Uvarova
Consulting and Diagnostic Center of the Altai Territory
Russian Federation
Russian Federation
Yulia M. Uvarova, Obstetrician-Gynecologist
Barnaul
T. I. Gorbacheva
Altai State Medical University;
Regional Clinical Hospital for Emergency Medical Care
Russian Federation
Russian Federation
Tatiana I. Gorbacheva, Cand. Sci. (Med), Associate Professor, Associate Professor of the Department;
Obstetrician-Gynecologist
Barnaul
References
1. MLA style: The Nobel Prize in Physiology or Medicine 2017. URL: http://nobelprize.org/prizes/medicine/2017/summary (accessed: 14.07.2025).
2. Khabarov S. V., Sterlikova N. A. Melatonin and its Role in Circadian Regulation of Reproductive Function (Literature Review). Vestnik novykh meditsinskikh tekhnologii = Bulletin of New Medical Technologies. 2022; 29 (3): 17–31. doi: 10.24412/1609-2163-2022-3-17-31 (In Russ.).
3. Guo Y. M., Sun T. C., Wang H. P., Chen X. Research progress of melatonin (MT) in improving ovarian function: a review of the current status. Aging (Albany NY). 2021; 13: 17930–17947. doi: 10.18632/aging.203231. PMID: 34228638. PMCID: PMC8312436.
4. Petrov Yu. A., Shelemakh K. E., Kupina A. D. The Effect of Melatonin on the Reproductive System in Different Life Stages. Mat i ditya v Kuzbasse = Mother and Child in the Kuzbass. 2021; 2 (85): 26–31. doi: 10.24411/2686-7338-2021-10019 (In Russ.).
5. Reiter R. J., Tamura H., Tan D. X., Xu X. Y. Melatonin and the circadian system: contributions to successful female reproduction. Fertility and Sterility. 2014; 102 (2): 321–328. doi: 10.1016/j.fertnstert.2014.06.014. PMID: 24996495.
6. Ferlazzo N., Andolina G., Cannata A., Costanzo M.G., Rizzo V., Currò M., Ientile R., Caccamo D. Is Melatonin the Cornucopia of the 21st Century. Antioxidants (Basel). 2020; 9 (11): 1088. doi: 10.3390/antiox9111088. PMID: 33167396. PMCID: PMC7694322.
7. Minich D. M., Henning M., Darley C., Fahoum M., Schuler C. B., Frame J. Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements. Nutrients. 2022; 14 (19): 3934. doi: 10.3390/nu14193934. PMID: 36235587. PMCID: PMC9571539.
8. Olcese J. M. Melatonin and Female Reproduction: An Expanding Universe. Front Endocrinol (Lausanne). 2020; 11: 85. doi: 10.3389/fendo.2020.00085. PMID: 32210911. PMCID: PMC7067698.
9. Lateef O. M., Akintubosun M. O. Sleep and Reproductive Health. J Circadian Rhythms. 2020; 18: 1. doi: 10.5334/jcr.190. PMID: 32256630. PMCID: PMC7101004.
10. Brzezinski A., Seibel M. M., Lynch H. J., Deng M. H., Wurtman R. J. Melatonin in human preovulatory follicular fluid. Journal of Clinical Endocrinology and Metabolism. 1987; 64: 865–867.
11. Li H., Liu M., Zhang C. Women with polycystic ovary syndrome (PCOS) have reduced melatonin concentrations in their follicles and have mild sleep disturbances. BMC Womens Health. 2022; 22 (1): 79. doi: 10.1186/s12905-022-01661-w. PMID: 35313872. PMCID: PMC8935689.
12. Jamilian M., Foroozanfard F., Mirhosseini N. et al. Effects of melatonin supplementation on hormonal, inflammatory, genetic, and oxidative stress parameters in women with polycystic ovary syndrome. Frontiers in Endocrinology. 2019; 10: 273. doi: 10.3389/fendo.2019.00273.16.
13. Tagliaferri V., Romualdi D., Scarinci E. Melatonin treatment may be able to restore menstrual cyclicity in women with PCOS: a pilot study. Reproductive Sciences. 2017; 25 (2): 269–275. doi: 10.1177/1933719117711262.
14. Andreeva O. V., Botasheva T. L., Rymashevskaya A. N., Latynin A. N., Petrov Yu. A., Zavodnov O. P. The role of melatonin and inhibin B in the pathogenesis of oligomenorrhea in adolescent girls. Reproduktivnoe zdorove detey i podrostkov = Reproductive health of children and adolescents. 2020; 16, 3 (88): 56–63 (In Russ.).
15. Zhao Y., Shao G., Liu X., Li Z. Assessment of the Therapeutic Potential of Melatonin for the Treatment of Osteoporosis Through a Narrative Review of Its Signaling and Preclinical and Clinical Studies. Frontiers in Pharmacology. 2022; 13: 866625. doi: 10.3389/fphar.2022.866625.
16. Stocker L. J., Macklon N. S., Cheong Y. C., Bewley S. J. Influence of shift work on early reproductive outcomes: a systematic review and meta-analysis. Obstetrics and Gynecology. 2014; 124 (1): 99–110.
17. Rahman S. A., Grant L. K., Gooley J. J., Rajaratnam S. M. W., Czeisler C. A., Lockley S. W. Endogenous Circadian Regulation of Female Reproductive Hormones. Journal of Clinical Endocrinology and Metabolism. 2019; 104 (12): 6049–6059. doi: 10.1210/jc.2019-00803. PMID: 31415086. PMCID: PMC6821202.
18. Greendale G. A., Witt-Enderby P., Karlamangla A. S., Munmun F., Crawford S., Huang M., Santoro N. Melatonin Patterns and Levels During the Human Menstrual Cycle and After Menopause. Journal of the Endocrine Society. 2020; 4 (11): bvaa115. doi: 10.1210/jendso/bvaa115. PMID: 33094207. PMCID: PMC7566378.
19. Wang Y., Liu S., Gan F., Xiong D., Zhang X., Zheng Z. Melatonin levels and embryo quality in IVF patients with diminished ovarian reserve: a comparative study. Reproductive Biology and Endocrinology. 2024; 22 (1): 127. doi: 10.1186/s12958-024-01296-6. PMID: 39415216. PMCID: PMC11481365.
20. Cosme P., Rodríguez A. B., Garrido M., Espino J. Coping with Oxidative Stress in Reproductive Pathophysiology and Assisted Reproduction: Melatonin as an Emerging Therapeutical Tool. Antioxidants (Basel). 2022; 12 (1): 86. doi: 10.3390/antiox12010086.
21. Danilova M. V., Usoltseva E. N. The Role of the Epiphysis Hormone Melatonin in Maintaining the Health of Women of Reproductive Age (Literature Review). Akusherstvo, ginekologiia i reproduktsiia = Obstetrics, Gynecology and Reproduction. 2019; 13 (4): 337–344. doi: 10.17749/2313-7347.2019.13.4.337-344 (In Russ.).
22. Yong W., Ma H., Na M., Gao T., Zhang Y., Hao L., Yu H., Yang H., Deng X. Roles of melatonin in the field of reproductive medicine. Biomedicine and Pharmacotherapy. 2021; 144: 112001. doi: 10.1016/j.biopha.2021.112001. PMID: 34624677.
23. Mejlhede M. A. B., Jepsen J. B., Knudsen U. B. Oral melatonin supplementation during in vitro fertilization treatment: a systematic PRISMA review and meta-analysis of randomized controlled trials. Gynecological Endocrinology. 2021; 37 (12): 1079–1085. doi: 10.1080/09513590.2021.1974378. PMID: 34494508.
24. Hu K. L., Ye X., Wang S., Zhang D. Melatonin Application in Assisted Reproductive Technology: A Systematic Review and Meta-Analysis of Randomized Trials. Frontiers in Endocrinology (Lausanne). 2020; 11: 160. doi: 10.3389/fendo.2020.00160.
25. Veiga E. C. A., Samama M., Ikeda F., Cavalcanti G. S., Sartor A., Parames S. F., Baracat E. C., Ueno J., Junior J. M. S. Melatonin improves fertilization rate in assisted reproduction: Systematic review and metaanalysis. Clinics (Sao Paulo). 20245; 79: 100397. doi: 10.1016/j.clinsp.2024.100397. PMID: 38971124. PMCID: PMC11265587.
26. Tamura H., Jozaki M., Tanabe M., Shirafuta Y., Mihara Y., Shinagawa M., Tamura I., Maekawa R., Sato S., Taketani T., Takasaki A., Reiter R. J., Sugino N. Importance of Melatonin in Assisted Reproductive Technology and Ovarian Aging. International Journal of Molecular Sciences. 2020; 21 (3): 1135. doi: 10.3390/ijms21031135. PMID: 32046301. PMCID: PMC7036809.
27. Swarnamani K., Davies-Tuck M., Wallace E., Mol B. W., Mockler J. A Double-Blind Randomised Placebo-Controlled Trial of Melatonin as an Adjuvant Agent in Induction of Labour (MILO): A Study Protocol. BMJ Open. 2020; 10: e032480.
28. Berbets A., Koval H., Barbe A., Albota O., Yuzko O. Melatonin decreases and cytokines increase in women with placental insufficiency. Journal of Maternal-Fetal and Neonatal Medicine. 2021; 34 (3): 373–378. doi: 10.1080/14767058.2019.1608432. PMID: 31023180.
29. Manna C., Lacconi V., Rizzo G., De Lorenzo A., Massimiani M. Placental Dysfunction in Assisted Reproductive Pregnancies: Perinatal, Neonatal and Adult Life Outcomes. International Journal of Molecular Sciences. 2022; 23 (2): 659. doi: 10.3390/ijms23020659. PMID: 35054845. PMCID: PMC8775397.
Review
For citations:
Nikolaeva M.G., Uvarova Yu.M., Gorbacheva T.I. Melatonin in the Context of Women's Health. Astrakhan medical journal. 2026;21(1):27-33. (In Russ.) https://doi.org/10.17021/1992-6499-2026-1-27-33
Views:
94
JATS XML
Email this article 